Retinal vascular and structural changes are associated with amyloid burden in the elderly: Ophthalmic biomarkers of preclinical Alzheimer's disease

Alzheimer's Research and Therapy

Volumn 9, Issue 1, 2017, Pages

  Golzan, S Mojtaba ^a,b   Goozee, Kathryn ^b,c,d,e   Georgevsky, Dana ^b   Avolio, Alberto ^b   Chatterjee, Pratishtha ^b,c   Shen, Kaikai ^f   Gupta, Vivek ^b   Chung, Roger ^b   Savage, Greg ^b   Orr, Carolyn F ^b   Martins, Ralph N ^b,c,e   Graham, Stuart L ^b  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

^c KaRa Institute of Neurological Disease   (Australia)

^d Anglican Retirement Village   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f CSIRO   (Australia)

Author keywords

Alzheimer's disease; Early diagnosis; Retinal imaging; Vascular biomarkers

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; FLORBETABEN;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD PRESSURE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PULSE WAVE; RETINA BLOOD VESSEL; RETINA GANGLION CELL; RETINAL NERVE FIBER LAYER THICKNESS; AMYLOID PLAQUE; BRAIN; COGNITIVE DEFECT; DIAGNOSTIC IMAGING; HEMODYNAMICS; ORGAN SIZE; PATHOPHYSIOLOGY; RETINA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; COGNITIVE DYSFUNCTION; COHORT STUDIES; FEMALE; HEMODYNAMICS; HUMANS; MALE; ORGAN SIZE; PLAQUE, AMYLOID; RETINA; RETINAL VESSELS;

EID: 85014415598     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/s13195-017-0239-9     Document Type: Article

References (53)

1. Koronyo Y, Salumbides BC, Black KL, Koronyo-Hamaoui M. Alzheimer's disease in the retina: imaging retinal Aβ plaques for early diagnosis and therapy assessment. Neurodegener Dis. 2012;10:285-93.
2. Moore KM, Girens RE, Larson SK, Jones MR, Restivo JL, Holtzman DM, et al. A spectrum of exercise training reduces soluble Aβ in a dose-dependent manner in a mouse model of Alzheimer's disease. Neurobiol Dis. 2016;85:218-24.
3. Holtzman DM, Morris JC, Goate AM. Alzheimer's disease: the challenge of the second century. Sci Transl Med. 2011;3:77sr1. doi: 10.1126/scitranslmed.3002369.
4. Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol. 2014;13:614-29.
5. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:263-9.
6. Johnson KA, Fox NC, Sperling RA, Klunk WE. Brain imaging in Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2:a006213.
7. Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, et al. Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association. J Nucl Med. 2013;54:476-90. doi: 10.2967/jnumed.113.120618.
8. Guo L, Duggan J, Cordeiro MF. Alzheimer's disease and retinal neurodegeneration. Curr Alzheimer Res. 2010;7:3-14.
9. Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, Miller CA, Ko MK, Black KL, et al. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage. 2011;54 Suppl 1:S204-17. doi: 10.1016/j.neuroimage.2010.06.020.
10. Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL. Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci. 2007;48:2285-9. http://www.ncbi.nlm.nih.gov/pubmed/17460292. Accessed 20 July 2012.
11. Paquet C, Boissonnot M, Roger F, Dighiero P, Gil R, Hugon J. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett. 2007;420:97-9. doi: 10.1016/j.neulet.2007.02.090.
12. Golzan SM, Morgan WH, Georgevsky D, Graham SL. Correlation of retinal nerve fibre layer thickness and spontaneous retinal venous pulsations in glaucoma and normal controls. PLoS One. 2015;10:e0128433. doi: 10.1371/journal.pone.0128433.
13. Lesage SR, Mosley TH, Wong TY, Szklo M, Knopman D, Catellier DJ, et al. Retinal microvascular abnormalities and cognitive decline: the ARIC 14-year follow-up study. Neurology. 2009;73:862-8. doi: 10.1212/WNL.0b013e3181b78436.
14. Patton N, Pattie A, MacGillivray T, Aslam T, Dhillon B, Gow A, et al. The association between retinal vascular network geometry and cognitive ability in an elderly population. Invest Ophthalmol Vis Sci. 2007;48:1995-2000. doi: 10.1167/iovs.06-1123.
15. Waldstein SR, Rice SC, Thayer JF, Najjar SS, Scuteri A, Zonderman AB. Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension. 2008;51:99-104. doi: 10.1161/HYPERTENSIONAHA.107.093674.
16. Elias MF, Robbins MA, Budge MM, Abhayaratna WP, Dore GA, Elias PK. Arterial pulse wave velocity and cognition with advancing age. Hypertension. 2009;53:668-73. doi: 10.1161/HYPERTENSIONAHA.108.126342.
17. Smith EE, Greenberg SM. Beta-amyloid, blood vessels, and brain function. Stroke. 2009;40:2601-6. doi: 10.1161/STROKEAHA.108.536839.
18. Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P, et al. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. Int Psychogeriatr. 2009;21:672-87. doi: 10.1017/S1041610209009405.
19. Golzan SM, Graham SL, Leaney J, Avolio A. Dynamic association between intraocular pressure and spontaneous pulsations of retinal veins. Curr Eye Res. 2011;36:53-9. doi: 10.3109/02713683.2010.530731.
20. 18F-florbetaben in Alzheimer disease and other dementias. J Nucl Med. 2011;52:1210-7.
21. Zeki Al Hazzouri A, Newman AB, Simonsick E, Sink KM, Sutton Tyrrell K, Watson N, et al. Pulse wave velocity and cognitive decline in elders: the Health, Aging, and Body Composition study. Stroke. 2013;44:388-93. doi: 10.1161/STROKEAHA.112.673533.
22. Pase MP, Herbert A, Grima NA, Pipingas A, O'Rourke MF. Arterial stiffness as a cause of cognitive decline and dementia: a systematic review and meta-analysis. Intern Med J. 2012;42:808-15. doi: 10.1111/j.1445-5994.2011.02645.x.
23. Ando J, Yamamoto K. Effects of shear stress and stretch on endothelial function. Antioxid Redox Signal. 2011;15:1389-403. doi: 10.1089/ars.2010.3361.
24. Suzuma I, Hata Y, Clermont A, Pokras F, Rook SL, Suzuma K, et al. Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: potential mechanisms for exacerbation of diabetic retinopathy by hypertension. Diabetes. 2001;50:444-54. doi: 10.2337/diabetes.50.2.444.
25. Katusic ZS, Austin SA. Endothelial nitric oxide: protector of a healthy mind. Eur Heart J. 2014;35:888-94. doi: 10.1093/eurheartj/eht544.
26. Austin SA, Santhanam AV, Katusic ZS. Endothelial nitric oxide modulates expression and processing of amyloid precursor protein. Circ Res. 2010;107:1498-502. doi: 10.1161/CIRCRESAHA.110.233080.
27. Baker ML, Marino Larsen EK, Kuller LH, Klein R, Klein BEK, Siscovick DS, et al. Retinal microvascular signs, cognitive function, and dementia in older person: the Cardiovascular Health Study. Stroke. 2007;38:2041-7.
28. Cheung CYL, Ong YT, Ikram MK, Ong SY, Li X, Hilal S, et al. Microvascular network alterations in the retina of patients with Alzheimer's disease. Alzheimers Dement. 2014;10:135-42. doi: 10.1016/j.jalz.2013.06.009.
29. Frost S, Kanagasingam Y, Sohrabi H, Vignarajan J, Bourgeat P, Salvado O, et al. Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease. Transl Psychiatry. 2013;3:e233. doi: 10.1038/tp.2012.150.
30. de Jong FJ, Schrijvers EMC, Ikram MK, Koudstaal PJ, de Jong PTVM, Hofman A, et al. Retinal vascular caliber and risk of dementia: the Rotterdam study. Neurology. 2011;76:816-21. https://www.ncbi.nlm.nih.gov/pubmed/21288987.
31. Kondo M, Wang L, Bill A. The role of nitric oxide in hyperaemic response to flicker in the retina and optic nerve in cats. Acta Ophthalmol Scand. 1997;75:232-5. http://www.ncbi.nlm.nih.gov/pubmed/9253963. Accessed 17 Jan 2013.
32. Dorner GT, Garhofer G, Kiss B, Polska E, Polak K, Riva CE, et al. Nitric oxide regulates retinal vascular tone in humans. Am J Physiol Heart Circ Physiol. 2003;285:H631-6. doi: 10.1152/ajpheart.00111.2003.
33. Stodtmeister R. Central retinal vein: its pulsation and pressure in glaucoma [in German]. Klin Monbl Augenheilkd. 2015;232:147-51. doi: 10.1055/s-0034-1383397.
34. Ventzke S, Priddy F, Spoerl E, Haustein M, Matthe E, Pillunat LE, et al. During Valsalva maneuver the pressure in the central retinal vein may be higher than the intraocular pressure [abstract]. Invest Ophthalmol Vis Sci. 2014;55:4335. http://iovs.arvojournals.org/article.aspx?articleid = 2269837. Accessed 3 Mar 2016.
35. Abegão Pinto L, Willekens K, Van Keer K, Shibesh A, Molenberghs G, Vandewalle E, et al. Ocular blood flow in glaucoma - the Leuven Eye Study. Acta Ophthalmol. 2016;94:592-8. doi: 10.1111/aos.12962.
36. Jonas JB, Ritch R, Panda-Jonas S. Cerebrospinal fluid pressure in the pathogenesis of glaucoma. Prog Brain Res. 2015;221:33-47. doi: 10.1016/bs.pbr.2015.06.002.
37. Jonas JB, Wang N, Yang D. Translamina cribrosa pressure difference as potential element in the pathogenesis of glaucomatous optic neuropathy. Asia Pac J Ophthalmol (Phila). 2016;5:5-10. doi: 10.1097/APO.0000000000000170.
38. Morgan WH, Hazelton ML, Azar SL, House PH, Yu DY, Cringle SJ, et al. Retinal venous pulsation in glaucoma and glaucoma suspects. Ophthalmology. 2004;111:1489-94. doi: 10.1016/j.ophtha.2003.12.053.
39. Sivak JM. The aging eye: common degenerative mechanisms between the Alzheimer's brain and retinal disease. Invest Ophthalmol Vis Sci. 2013;54:871-80. doi: 10.1167/iovs.12-10827.
40. Ou Y, Grossman DS, Lee PP, Sloan FA. Glaucoma, Alzheimer disease and other dementia: a longitudinal analysis. Ophthalmic Epidemiol. 2012;19:285-92. doi: 10.3109/09286586.2011.649228.
41. Bayer AU, Ferrari F, Erb C. High occurrence rate of glaucoma among patients with Alzheimer's disease. Eur Neurol. 2002;47:165-8.
42. Stone J, Johnstone DM, Mitrofanis J, O'Rourke M. The mechanical cause of age-related dementia (Alzheimer's disease): the brain is destroyed by the pulse. J Alzheimers Dis. 2015;44:355-73. doi: 10.3233/JAD-141884.
43. Drance SM. Disc hemorrhages in the glaucomas. Surv Ophthalmol. 1989;33:331-7. http://www.ncbi.nlm.nih.gov/pubmed/2655138. Accessed 22 Mar 2016.
44. Gao L, Liu Y, Li X, Bai Q, Liu P. Abnormal retinal nerve fiber layer thickness and macula lutea in patients with mild cognitive impairment and Alzheimer's disease. Arch Gerontol Geriatr. 2015;60:162-7. doi: 10.1016/j.archger.2014.10.011.
45. Pillai JA, Bermel R, Bonner-Jackson A, Rae-Grant A, Fernandez H, Bena J, et al. Retinal nerve fiber layer thinning in Alzheimer's disease: a case-control study in comparison to normal aging, Parkinson's disease, and non-Alzheimer's dementia. Am J Alzheimers Dis Other Demen. 2016;31:430-6. doi: 10.1177/1533317515628053.
46. Garcia-Martin E, Bambo MP, Marques ML, Satue M, Otin S, Larrosa JM, et al. Ganglion cell layer measurements correlate with disease severity in patients with Alzheimer's disease. Acta Ophthalmol. 2016;94:e454-9. doi: 10.1111/aos.12977.
47. Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL. Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci. 2007;48:2285-9. doi: 10.1167/iovs.06-1029.
48. de la Torre JC. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol. 2004;3:184-90. http://www.sciencedirect.com/science/article/pii/S1474442204006830. Accessed 19 Nov 2013.
49. de la Torre JC. Alzheimer disease as a vascular disorder: nosological evidence. Stroke. 2002;33:1152-62. doi: 10.1161/01.STR.0000014421.15948.67.
50. Faraco G, Iadecola C. Hypertension: a harbinger of stroke and dementia. Hypertension. 2013;62:810-7. doi: 10.1161/HYPERTENSIONAHA.113.01063.
51. Dede DS, Yavuz B, Yavuz BB, Cankurtaran M, Halil M, Ulger Z, et al. Assessment of endothelial function in Alzheimer's disease: is Alzheimer's disease a vascular disease? J Am Geriatr Soc. 2007;55:1613-7. doi: 10.1111/j.1532-5415.2007.01378.x.
52. Poels MMF, Zaccai K, Verwoert GC, Vernooij MW, Hofman A, van der Lugt A, et al. Arterial stiffness and cerebral small vessel disease: the Rotterdam Scan Study. Stroke. 2012;43:2637-42. doi: 10.1161/STROKEAHA.111.642264.
53. Cifuentes D, Poittevin M, Dere E, Broquères-You D, Bonnin P, Benessiano J, et al. Hypertension accelerates the progression of Alzheimer-like pathology in a mouse model of the disease. Hypertension. 2015;65:218-24.